Lymphocytic Esophagitis: An Emerging Clinicopathologic Disease Associated with Dysphagia by Pasricha, Sarina et al.
Lymphocytic Esophagitis: An emerging clinicopathologic 
disease associated with dysphagia
Sarina Pasricha, MD1, Amit Gupta, MD2, Craig C. Reed, MD1, Olga Speck, MD PhD3, John T. 
Woosley, MD PhD3, and Evan S. Dellon, MD, MPH1
1University of North Carolina at Chapel Hill, Center for Esophageal Diseases and Swallowing, 
Division of Gastroenterology and Hepatology, Chapel Hill, NC
2University of Michigan, Department of Medicine, Ann Arbor MI
3University of North Carolina at Chapel Hill, Department of Pathology and Laboratory Medicine, 
Chapel Hill, NC
Abstract
Background—Lymphocytic Esophagitis (LyE) is a recently described clinicopathological 
condition, but little is known about its features and clinical associations.
Aim—To characterize patients with LyE, compare them to non-LyE controls, and identify risk 
factors.
Methods—We conducted a retrospective study of all patients ≥18 years old who underwent 
upper endoscopy with esophageal biopsy between January 1, 2000 and June 1, 2012. Archived 
pathology slides were re-reviewed and LyE was diagnosed if there was lymphocyte-predominant 
esophageal inflammation with no eosinophils or granulocytes. Three non-LyE controls groups 
were also defined: reflux, eosinophilic esophagitis (EoE), and normal. Clinical data were extracted 
from electronic medical records, and LyE cases were compared to non-LyE controls.
Results—27 adults were diagnosed with LyE, and the majority were female (63%). The most 
common symptom was dysphagia (70%). 52% had a prior or current diagnosis of reflux. 
Endoscopic findings included strictures (37%), erosive esophagitis (33%), rings (26%), and hiatal 
hernia (26%); 33% of patients required dilation. After histology re-review, 78% of LyE patients 
were found to have more than 20 lymphs/hpf. In comparison to the normal, reflux and EoE 
controls, patients with LyE tended to be non-white (p<0.01), were more commonly tobacco users 
(p=0.02), and less likely to have seasonal allergies (p=0.02).
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Conclusion—LyE commonly presents with dysphagia due to esophageal strictures which require 
dilation. Smoking was associated with LyE whereas atopy was not. LyE should be considered as a 
diagnostic possibility in patients with these characteristics undergoing upper endoscopy.
Keywords
Lymphocyte; dysphagia; heartburn; chest pain; endoscopy
Introduction
Lymphocytic Esophagitis (LyE) is a recently described histopathological condition first 
defined by Rubio et al. in 2006 as a histologic subset of chronic esophagitis characterized by 
>20 intraepithelial lymphocytes (IELs) per high-power field (HPF) with no more than rare 
granulocytes [1]. Subsequently, as recognition of this histopathologic condition has become 
more widespread, there has also been some controversy related to LyE as studies have both 
questioned prior findings and attempted to better characterize this new entity [2–8].
No definite clinical associations have been detected in adults, though both gastroesophageal 
reflux disease (GERD) and Crohn’s disease have been linked to LyE [9,10]. Because of the 
relative rarity of LyE, consensus regarding the defining features and clinical associations still 
does not exist and great variation has been present in sample sizes and control groups. We 
have clinically encountered patients with LyE and found diagnosis and management to be a 
challenge due to lack of data.
Therefore, the aim of our study was to characterize adult patients with LyE. We sought to 
compare patients with LyE to non-LyE controls (GERD, eosinophilic esophagitis (EoE), and 
normal on esophageal biopsy) and to identify risk factors for the condition and endoscopic 
findings.
Methods
We performed a retrospective study of all patients ≥18 years old who had undergone upper 
endoscopy (EGD) with esophageal biopsy at the University of North Carolina at Chapel Hill 
between January 1, 2000, and June 1, 2012. In order to identify a cohort of patients who 
could have LyE, all pathology reports from this time frame were searched for terms 
referencing increased lymphocytes or a lymphocyte-predominant infiltrate as these were 
broad terms that could capture LyE diagnoses, even if the LyE itself was not recognized at 
the time of the prior endoscopy. The archived pathology slides were acquired for these cases 
and were independently re-reviewed by a study pathologist who was blinded to the original 
diagnoses. As there are no published diagnostic guidelines and we wanted to be broad in 
identifying potential cases, LyE was diagnosed if there were ≥10 lymphocytes/hpf 
(hpf=0.24mm2) in the esophageal epithelium and no eosinophils or granulocytes.
Three non-LyE control groups were also defined by reviewing the above pathology database 
and selecting the first 20 patients with biopsy findings consistent with the following 
diagnoses: 1) patients with GERD (defined by clinical symptoms and a mixed inflammatory 
pattern on biopsy); 2) patients with eosinophilic esophagitis (EoE) (defined by consensus 
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guidelines); [11] and 3) patients with a normal esophageal biopsy. Patients with “normal” 
esophageal biopsy are believed to be reflective of our general population at UNC undergoing 
endoscopic evaluation. Patients with vasculitis, lichen planus, leukemia, infectious 
esophagitis (cytomegalovirus, herpes, candida), graft vs host disease, or multiple myeloma 
were excluded [11,12].
Data including patient demographics, co-morbidities, tobacco or alcohol use, medications, 
endoscopic findings, treatment, and outcomes were independently extracted for all four 
study groups from electronic medical records, pathology reports, and endoscopic databases 
at UNC, by two separate reviewers. The reviewers then compared findings and re-reviewed 
data jointly to reach consensus on any points of discrepancy. If there was still disagreement, 
the data were adjudicated by the senior author.
Descriptive statistics was performed to summarize characteristics of patients with LyE. One 
way analysis of variance and chi squared testing were done to compare patients with LyE to 
controls, GERD patients, and EoE patients using Stata 13. IRB approval was obtained at the 
University of North Carolina prior to initiation of the study.
Results
A total of 27 patients with LyE were identified, with the first diagnosis made in 2004. The 
average age was 56 years, most patients were female (63%) and white (59%) (Table 1). The 
most common symptoms at presentation were dysphagia (70%), heartburn (26%), chest pain 
(19%), nausea/vomiting (19%), and abdominal pain (15%). About half of patients had a 
prior or current history of alcohol and tobacco use, and the most commonly used 
medications were proton-pump inhibitors (59%) and non-steroidal anti-inflammatory drugs 
(64%).
For concomitant conditions, one patient (4%) had been previously diagnosed with 
inflammatory bowel disease and 14 (52%) had a current or prior diagnosis of GERD (Table 
1). Atopic conditions were not common in this group with 1 patient (4%) with a history of 
food allergy, 1 (4%) with seasonal allergies, 5 (19%) with asthma, and 1 (4%) with eczema.
The vast majority of patients had an abnormal upper endoscopy (82%) at diagnosis (Table 
2). Endoscopic findings included a narrow caliber esophagus (44%), esophageal stricture 
(37%), erosive esophagitis as defined endoscopically (33%), esophageal rings (26%), 
erythema (26%), and hiatal hernia (26%) (Figure 1). Esophageal dilation was performed in 9 
patients (33%). Of the patients who had strictures, 30% were pan-esophageal (representing 
diffuse esophageal narrowing), 30% were proximal, and 40% were distal.
On histologic re-examination of the original biopsy slides, 52% of patients had between 21–
40 lymphocytes/hpf, 4% had between 41–80 lymphocytes/hpf and 22% had greater than 80 
lymphocytes/hpf (Figure 2) (Table 2).
Based on the clinical and histologic findings, 9 patients had a medication change. These 
included: initiation or increase in proton-pump inhibitor dose in 6 patients, addition of a GI 
cocktail in 1, initiation of swallowed fluticasone in 1, and initiation of oral prednisone taper 
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in 1 (Table 2). Of the patients who had a medication change, only 1 patient had follow up 
EGD, 2 patients who were started on a PPI and 1 patient who was treated with swallowed 
fluticasone had symptomatic improvement.
When patients with LyE were compared to patients with a normal esophageal biopsy, 
patients with GERD, and patients with eosinophilic esophagitis (Table 3), patients with LyE 
were more likely to be non-white (41% vs. 15% normal vs. 0% GERD vs. 5% EoE; p < 
0.01) and use tobacco (64% vs. 30% normal vs. 55% GERD vs. 55% EoE; p = 0.02). LyE 
patients had comparable rates of drug and food allergies, but were less likely to have allergic 
rhinitis (4% vs. 25% normal vs. 25% GERD vs. 40% EoE; p =0.02). Other clinical features 
were similar.
Discussion
LyE is a recently described rare condition of the esophagus. It has not yet been well 
characterized, and correlation between the histologic findings and clinical features are not 
always clear [3,8,9,10,13,14]. Because of this, we aimed to characterize patients with LyE at 
our center, compare them to non-LyE controls, and identify risk factors in order to provide 
more data to guide care. In sum, we found 27 adults diagnosed with LyE starting as early as 
2004, and the vast majority of patients had more than 20 lymphs/hpf on histology. Diagnosis 
tended to be in the 6th decade, and in comparison to our GERD, EoE and “normal” controls, 
patients with LyE tended to be non-white, were more commonly tobacco users, and less 
likely to have atopy. In contrast to EoE, there was also a female preponderance in LyE. 
However, in comparison to patients with “normal” findings, there were fewer females 
diagnosed with LyE, though this group still had a majority of females. In addition, we did 
not see a clear relation between LyE and Crohn’s disease, though previously diagnosed 
GERD was common. Of note, 85% of the patients in our “normal” cohort were Caucasian 
which is consistent with prior racial demographic data from the University of North Carolina 
[15].
From a symptom standpoint, our data is consistent with several other studies that have also 
noted dysphagia to be the most common symptom at presentation of LyE [2,16]. Relatively 
few of our patients complained of other upper GI symptoms such as heartburn, abdominal 
pain, chest pain, nausea/vomiting, or odynophagia, which is similar to other studies 
[2,3,5,16,17]. However, the possible association between smoking and LyE has not been 
previously observed. The pathogenesis of LyE is yet unknown, but it has been hypothesized 
that possible causes of LyE may include a hypersensitivity reaction to an ingestant or an 
autoimmune phenomenon [1,3,4,14]. Additionally, it has been proposed that LyE may be an 
early sign of GERD in patients with no other endoscopic findings [10,18]. Given our finding 
of a significant association with smoking, it is intriguing to speculate whether an element of 
cigarette smoke may act as a topical trigger of the condition. However, further studies 
investigating the association with smoking are needed to confirm our findings and determine 
any etiologic mechanisms.
Several studies have reported an association between LyE and inflammatory bowel disease, 
but this has not been consistent. For example, Rubio et. al compared 20 patients with LyE to 
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61 patients with other types of esophagitis and found an association of LyE with Crohn’s 
disease (CD), particularly amongst pediatric patients [1]. Similarly, in a pediatric population 
with known Crohn’s disease, 28% of those patients were found to have increased 
lymphocytes [9]. A large pediatric cohort study by Sutton et. al found a significant 
association of CD in children with LyE (19% of children with LyE had CD and 12% of 
children with CD had LyE) [3,19]. This was not replicated in the study conducted by Purdy 
et. al [3]. A less frequent association was found in a study among adults by Basseri et. al [6]. 
Additionally, in a study of a very large esophageal biopsy database, Haque and Genta found 
that in adults, LyE affects predominantly older women and is not associated with CD [5]. In 
our study, we identified only one patient with concomitant inflammatory bowel disease 
(Crohn’s disease).
It is important to differentiate between esophageal lichen planus and LyE. The most 
characteristic histologic finding in esophageal lichen planus is a bandlike or lichenoid 
lymphocytic infiltrate obscuring the interface between lamina propria and basal layer 
epithelium, with or without Civatte bodies. The histologic lesions illustrated in our report 
lack a lichenoid infiltrate. Lymphocytes are numerous, but they are generally distributed 
uniformly within a spongiotic epithelium. Lymphocyte-mediated epithelial cell injury is 
present in most lesions, but the injury is higher in the epithelial layer. Therefore, we believe 
that LyE is a different histologic entity than lichen planus, and the two do not overlap in our 
series.
Limitations of our study include the fact that this was a retrospective case series at a single 
center. Therefore, we did not have standardized follow up data and there were few patients 
who had repeat endoscopic assessments. Because of the relatively small number of cases, we 
were unable to control for potential confounders or perform detailed sub-analyses. However, 
there were also several strengths. We conducted an exhaustive review of pathologic records 
to capture all patients with possible LyE, even if the diagnosis had not been made clinically, 
and then confirmed the diagnosis of our cases after re-review of pathology slides by an 
expert pathologist. This strategy yielded a cohort size that is comparable to other studies. 
Additionally, we compared our findings in patients with LyE to patients with normal 
esophagus, GERD, and EoE controls to help contextualize the findings and identify risk 
factors.
In conclusion, though it is rare, LyE should be considered as a diagnostic possibility in 
patients with clinical symptoms of dysphagia undergoing upper endoscopy. Our data would 
suggest it is more likely to be seen in older female patients who smoke and who do not have 
atopy. With wider recognition of LyE it is also important to ensure training of pathologists to 
recognize this condition and ensure semi-quantitative reporting of lymphocyte numbers 
noted when clinically appropriate. Larger studies are needed to better characterize LyE and 
gain information on the natural history of this condition.
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Figure 1. 
Endoscopic findings of patients with lymphocytic esophagitis illustrating narrow caliber 
esophagus, esophageal strictures, fine esophageal rings/webs, and erythema.
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Figure 2. 
Histologic findings of patients with lymphocytic esophagitis showing esophageal squamous 
mucosa with variable spongiosis and increased numbers of intraepithelial lymphocytes in a 
diffuse distribution, ranging in numbers from mild to striking, occasionally forming small 
lymphocytic clusters, particularly in the peripapillary areas.
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Table 1
Baseline Characteristics of LyE Patients (n = 27)
Age, yrs (mean ± SD) 56 ± 16
Male, n (%) 10 (37)
Caucasian, n (%) 16 (59)
BMI, kg/m2 (mean ± SD) 27 ± 9
Year of initial diagnosis, n (%)
  2004 1 (4)
  2005 2 (7)
  2007 1 (4)
  2008 3 (11)
  2009 5 (18)
  2010 5 (18)
  2011 8 (30)
  2012 2 (7)
Symptoms, n (%)
Dysphagia 19 (70)
Asymptomatic 3 (11)
Heartburn 7 (26)
Abdominal Pain 4 (15)
Chest Pain 5 (19)
Nausea/vomiting 5 (19)
Odynophagia 1 (4)
Pertinent Medical History, n (%)
Hx of Crohn’s disease 1 (4)
Hx of Ulcerative colitis 0
Hx of or active GERD 14 (52)
Hx of BE 0
Hx of EoE 1 (4)
Hx of Achalasia 1 (4)
Hx of Drug medication allergies 10 (37)
Hx of Food allergies 1 (4)
Hx of Seasonal allergies 1 (4)
Hx of Asthma 5 (19)
Hx of Eczema 1 (4)
Hx of IBS 3 (11)
Hx of cancer 4 (14)
Habits, n (%)
Alcohol Use (prior or current) 10 (37)
Tobacco Use (prior or current) 13 (48)
Pertinent Medication History, n (%)
PPI use, n (%) 15 (59)
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NSAID use (n=11), n (%) 7 (64)
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Table 2
Endoscopic findings, Lymphocytic count and Treatment
n (%)
Endoscopic Findings
 Abnormal 23 (82)
 Narrow Caliber 12 (44)
 Esophageal Stricture 10 (37)
 Esophageal Rings 7 (26)
 Erythema 7 (26)
 Hiatal Hernia 7 (26)
 Erosive Esophagitis 9 (33)
 Mucosal Pallor 3 (11)
 Abnormal Vascular Pattern 2 (7)
 Desquamation 2 (7)
 Ulcer 1 (4)
 Candidiasis 4 (15)
Lymphocyte Count (n =25)
 10–20 lymph/hpf 4 (15)
 21–40 lymph/hpf 14 (52)
 41–80 lymph/hpf 1 (4)
 >80 lymph/hpf 6 (22)
Medication Added or Changed After Endoscopy
 PPI daily 6 (22)
 GI cocktail (Maalox, viscous lidocaine, and donnatal) 1 (4)
 Fluticasone 1(4)
 Prednisone Taper 1(4)
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